La semaglutida cuesta entre $199 y $259 al mes, y la tirzepatida entre $275 y $499 al mes
Beneficios hepticos: Estudios preliminares sugieren que tirzepatide puede beneficiar a pacientes con enfermedad metablica asociada a esteatosis heptica (MASLD, anteriormente NAFLD), una condicin prevalente en personas con obesidad abdominal
Regular follow-up, monitoring of blood sugar, kidney, and liver tests when indicated, and active management of side effects help reduce long-term complications
Two studies were carried out in healthy subjects to investigate the effects of semaglutide on the pharmacokinetics of four therapies that are commonly co-administered with GLP-1RAs [14,15,16] and are characterised by differing properties of solubility and intestinal permeability [17]
We dont have a specific recommendation for what they should be, as the FDA has a better understanding of their costs than we do